Search

everythinglearnresearchcommunity

for

Search:↓

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The chemical peel improved the appearance of hand spots safely and effectively.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Loss of Ten1 in mice causes telomere shortening and symptoms similar to human dyskeratosis congenita.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

The document's conclusion cannot be summarized because the content is not available.

A natural compound called VB-1 can help promote hair growth by boosting a specific cell signal in human skin cells.

Scientists can control how skin stem cells divide by using different treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

A new treatment for hair loss shows promise with fewer side effects.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Dopamine receptors in the brain influence itch-related scratching behavior.

Grasp protein helps maintain skin health after UVB exposure.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.